Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter

All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.

NCT Number	NCT06333327
Lead Sponsor	Universitair Ziekenhuis Brussel
Conditions	Atrial Fibrillation
Enrollment	2,000 participants
Start Date	2021-01-01
Primary Completion	2030-01-01 (estimated)
Study Completion	2030-12-01 (estimated)
Updated on ClinicalTrials.gov	2024-03-27